InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
5
Disclosed sells
0
T+90 hit rate
29%
T+90 mean return
-21.4%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Kelly Timothy Edwin, Chief Financial Officer. Director active across 1 company, notably Praxis Precision Medicines, Inc.. Cumulatively, 18 filings have been published. Split: 5 buys · 0 sell. Total volume traded: €158k. Activity tracked since 31 August 2021. The latest transaction was filed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations18 total
249 shares@ US$31.5353.1% of flowCommon StockSEC:0001689548-25-000065:0
12,500 shares0Common StockSEC:0001689548-25-000014:0
139 shares@ US$77.524.5% of flowCommon StockSEC:0001689548-25-000005:0
205 shares@ US$37.403.2% of flowCommon StockSEC:0001104659-24-120746:0
7,800 shares0Common StockSEC:0001104659-24-084502:0
606 shares@ US$12.3683.0% of flowCommon StockSEC:0001689548-24-000064:0
139 shares@ US$25.191.4% of flowCommon StockSEC:0001689548-24-000008:0
11,683 shares@ US$0.8844.1% of flowCommon StockSEC:0001689548-23-000092:0
8,000 shares@ US$0.87472.8% of flowCommon StockSEC:0001104659-23-042818:0
Ideal exit: 19 Dec 2023 (T+270)
8,000 shares@ US$0.87472.8% of flowCommon StockSEC:0001104659-23-037021:0
Ideal exit: 19 Dec 2023 (T+270)
2,079 shares@ US$2.522.2% of flowCommon StockSEC:0001689548-23-000005:0
5 shares@ US$1.8110.0% of flowCommon StockSEC:0001689548-22-000129:0
10,000 shares@ US$1.7650.0002% mcap9.9% of flowCommon StockSEC:0001689548-22-000078:0
Ideal exit: 6 Mar 2023 (T+270)
2,585 shares@ US$8.7980.0003% mcap13.1% of flowCommon StockSEC:0001689548-22-000042:0
24,000 shares0Common StockSEC:0001104659-22-003155:0
24,000 shares0Common StockSEC:0001104659-22-003155
3,905 shares@ US$19.480.0009% mcap38.5% of flowCommon StockSEC:0001689548-21-000083:0
Ideal exit: 28 May 2022 (T+270)
3,905 shares@ US$19.4828.1% of flowCommon StockSEC:0001689548-21-000083
Ideal exit: 28 May 2022 (T+270)
18 of 18 declarations
About Kelly Timothy Edwin
Timothy Edwin Kelly is the Chief Financial Officer at Praxis Precision Medicines, Inc. He is responsible for the company's financial management, including financial planning, risk management, and compliance. With a strong background in finance, he contributes to the overall financial strategy and informed decision-making to support Praxis' growth. His role is crucial in ensuring the financial health of the company.
